Home LiteratureArticle Details
PMID: 18165275 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays.

The Journal of molecular diagnostics : JMD ·Vol. 10 ·No. 1 ·2008-01-00 ·Pages 50-7

Jhavar S, Reid A, Clark J, Kote-Jarai Z, Christmas T, Thompson A, Woodhouse C, Ogden C, Fisher C, Corbishley C, De-Bono J, Eeles R, Brewer D, Cooper C

Abstract

Translocation of TMPRSS2 to the ERG gene, found in a high proportion of human prostate cancer, results in overexpression of the 3'-ERG sequences joined to the 5'-TMPRSS2 promoter. The studies presented here were designed to test the ability of expression analysis on GeneChip Human Exon 1.0 ST arrays to detect 5'-TMPRSS2-ERG-3' hybrid transcripts encoded by this translocation. Monitoring the relative expression of each ERG exon revealed altered transcription of the ERG gene in 15 of a series of 27 prostate cancer samples. In all cases, exons 4 to 11 exhibited enhanced expression compared with exons 2 and 3. This pattern of expression indicated that the most abundant hybrid transcripts involve fusions to ERG exon 4, and RT-PCR analyses confirmed the joining of TMPRSS2 exon 1 to ERG exon 4 in all 15 cases. The exon expression patterns also indicated that TMPRSS2-ERG fusion transcripts commonly contain deletion of ERG exon 8. Analysis of gene-level data from the arrays allowed the identification of genes whose expression levels significantly correlated with the presence of the translocation. These studies demonstrate that expression analyses using exon arrays represent a valuable approach for detecting ETS gene translocation in prostate cancer, in parallel with analyses of gene expression profiles.

MeSH Terms
DNA-Binding Proteins/genetics Exons/genetics Gene Expression Profiling/methods Gene Expression Regulation, Neoplastic Genes, Neoplasm Humans Male Oligonucleotide Array Sequence Analysis/methods Oncogene Proteins, Fusion/genetics Prostatic Neoplasms/diagnosis,genetics RNA, Messenger/genetics,metabolism Reverse Transcriptase Polymerase Chain Reaction Trans-Activators/genetics Transcriptional Regulator ERG Translocation, Genetic
Chemicals
DNA-Binding Proteins ERG protein, human Oncogene Proteins, Fusion RNA, Messenger TMPRSS2-ERG fusion protein, human Trans-Activators Transcriptional Regulator ERG
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Jhavar Sameer
Institute of Cancer Research, Male Urological Cancer Research Centre, Sutton, Surrey SM2 5NG, UK.
Reid Alison
Clark Jeremy
Kote-Jarai Zsofia
Christmas Timothy
Thompson Alan
Woodhouse Christopher
Ogden Christopher
Fisher Cyril
Corbishley Cathy
De-Bono Johann
Eeles Rosalind
Brewer Daniel
Cooper Colin
References (19)
19 references, click to expand
  1. Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.
    Cancer. 2005 Jul 15;104(2):290-8 PMID: 15948174
  2. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
    BMC Genomics. 2006;7:325 PMID: 17192196
  3. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
    Cancer Cell. 2005 Nov;8(5):393-406 PMID: 16286247
  4. Defining aggressive prostate cancer using a 12-gene model.
    Neoplasia. 2006 Jan;8(1):59-68 PMID: 16533427
  5. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma.
    EMBO J. 1995 May 15;14(10):2333-40 PMID: 7539744
  6. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
    Cancer Res. 2006 Nov 15;66(22):10658-63 PMID: 17108102
  7. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
    Cancer Res. 2006 Apr 1;66(7):3396-400 PMID: 16585160
  8. Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development.
    J Cell Biol. 2000 Jul 10;150(1):27-40 PMID: 10893254
  9. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
    Cancer Res. 2006 Nov 1;66(21):10242-6 PMID: 17079440
  10. Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
    Stat Appl Genet Mol Biol. 2004;3:Article3 PMID: 16646809
  11. Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.
    J Clin Pathol. 2005 May;58(5):504-8 PMID: 15858122
  12. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
    Cancer Res. 2006 Sep 1;66(17):8337-41 PMID: 16951139
  13. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.
    Neoplasia. 2006 Jun;8(6):465-9 PMID: 16820092
  14. Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.
    Cancer Biol Ther. 2007 Jan;6(1):40-5 PMID: 17172822
  15. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate.
    Oncogene. 2007 Apr 19;26(18):2667-73 PMID: 17043636
  16. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.
    Cancer Res. 2006 Sep 1;66(17):8347-51 PMID: 16951141
  17. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
    Science. 2005 Oct 28;310(5748):644-8 PMID: 16254181
  18. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
    Oncogene. 2007 Jul 5;26(31):4596-9 PMID: 17237811
  19. Summaries of Affymetrix GeneChip probe level data.
    Nucleic Acids Res. 2003 Feb 15;31(4):e15 PMID: 12582260
Article Info
Journal
The Journal of molecular diagnostics : JMD
Abbr.
J Mol Diagn
ISSN
1525-1578
Published
2008-01-00
Epub
2007-00-28
Pages
50-7
Language
English
Region
United States
NLM ID
100893612
PMCID
PMC2175543
Subset
IM
Grants
Medical Research Council · G0501019 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]